<DOC>
	<DOCNO>NCT02661737</DOCNO>
	<brief_summary>To evaluate long-term safety YVOIRE volume incidence adverse event include injection site local reaction biodegradability .</brief_summary>
	<brief_title>Observational Study Evaluate Long-term Safety Biodegradability YVOIRE Volumes</brief_title>
	<detailed_description />
	<criteria>1 . Subjects whose age 18 year old 65 year old 2 . Subjects whose WSRS grade equal great 2 3 . Subjects must willing able provide write informed consent form 4 . Subjects schedule treated YVOIRE volume facial tissue augmentation correct nasolabial fold 1 . Subjects sensitive hyaluronic acid excipients YVOIRE volume 2 . Subjects receive permanent implantation ( silicone , PAAG , PMMA , CaHA etc ) nasolabial fold 3 . Subjects receive nonpermanent aesthetic treatment , botulinum toxin injection filler nasolabial fold within 9 month screen 4 . Subjects receive face lift plastic surgery face within 9 month screen 5 . Subjects receive laser therapy nasolabial fold , chemical peel peel face within 3 month screen 6 . Subjects skin disease ( include inflammation skin cancer ) infectious disease injection sit 7 . Subjects tend hypertrophic scar 8 . Subjects history streptococcal disease , severe allergy anaphylaxis bleed disorder . 9 . Women pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>